one-hundred-eleven patients participated in a 21-day , open-label study to evaluate the therapeutic efficacy and safety of a prednisolone acetate 1 % -gentamicin 0.3 % ophthalmic suspension to control inflammation and prevent infection after cataract surgery .
C3555176
prednisolone acetate
C0021368
inflammation